GLAND.NS Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 apr 2024 @ 12:00):

Stats
Dagens volum	219 405
Gjennomsnittsvolum	497 818
Markedsverdi	284.83B
EPS	INR11.65 ( 2024-02-14 )
Neste inntjeningsdato	( INR13.32 ) 2024-05-15
Last Dividend	INR0 ( N/A )
Next Dividend	INR0 ( N/A )
P/E	43.32
ATR14	INR1.733 (0.10%)

Volum Korrelasjon

Lang: 0.17 (neutral)

Kort: 0.09 (neutral)

Signal:(48.7) Neutral

Gland Pharma Limited Korrelasjon

10 Mest positive korrelasjoner
PIDILITIND.NS	0.939
AARTIIND.NS	0.936
PAGEIND.NS	0.935
BRFL.NS	0.934
ATUL.NS	0.933
DEVYANI.NS	0.932
MSUMI.NS	0.926
MCDOWELL-N.NS	0.922
RAJMET.NS	0.918
PIXTRANS.NS	0.917

10 Mest negative korrelasjoner
GENCON.NS	-0.915
DFMFOODS.NS	-0.9
JSL.NS	-0.89
MBAPL.NS	-0.885
SUNFLAG.NS	-0.875
MAGNUM.NS	-0.873
TOUCHWOOD.NS	-0.857
ACI.NS	-0.856
GTNIND.NS	-0.854
RAJRILTD.NS	-0.853

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Gland Pharma Limited Korrelasjon - Valuta/Råvare

-0.67
( moderate negative )

-0.71
( moderate negative )

-0.81
( strong negative )

-0.61
( weak negative )

0.78
( moderate )

0.64
( weak )

Gland Pharma Limited Økonomi

Annual	2022
Omsetning:	INR36.25B
Bruttogevinst:	INR19.39B (53.50 %)
EPS:	INR47.44

FY	2022
Omsetning:	INR36.25B
Bruttogevinst:	INR19.39B (53.50 %)
EPS:	INR47.44

FY	2022
Omsetning:	INR43.84B
Bruttogevinst:	INR22.75B (51.89 %)
EPS:	INR73.81

FY	2021
Omsetning:	INR34.24B
Bruttogevinst:	INR19.32B (56.42 %)
EPS:	INR63.07

Financial Reports:

No articles found.

Gland Pharma Limited

Gland Pharma Limited engages in the development, manufacture, and marketing of injectable-focused generic liquid parenteral products. The company's primary molecules include heparin sodium, enoxaparin sodium, rocuronium bromide, and daptomycin injections, as well as others. It offers its products under various therapeutic categories, such as anti-infectives, anesthetics, anti-coagulants and their antidotes, anti-malarial, cardiology, gastro-intestinal, pain management, hormones and related drugs, fertility supplements, Gnrh agonists and antagonists, anti-neoplastic, gynecological, neurological and central nervous system, respiratory, blood related, ophthalmological and otological, pain/analgesics, orthopedics, hematinic, vitamins/minerals/nutrients, and others. The company also provides contract development services. It sells its products primarily under a business to business in the United States, Europe, Canada, Australia, India, and internationally. The company was incorporated in 1978 and is based in Hyderabad, India. Gland Pharma Limited is a subsidiary of Fosun Pharma Industrial Pte. Ltd.